anmelden
OMX Stockholm PI
1.138,66
PKT
-1,01
PKT
-0,09
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Stockholm PI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.04.14 | Ericsson (Telefon L.M.Ericsson) (B) buy | Société Générale Group S.A. (SG) | |
| 24.04.14 | Ericsson (Telefon L.M.Ericsson) (B) Outperform | Credit Suisse Group | |
| 24.04.14 | Ericsson (Telefon L.M.Ericsson) (B) buy | Deutsche Bank AG | |
| 24.04.14 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.04.14 | Ericsson (Telefon L.M.Ericsson) (B) Outperform | Bernstein Research | |
| 22.04.14 | AstraZeneca buy | Citigroup Corp. | |
| 17.04.14 | AstraZeneca Underweight | JP Morgan Chase & Co. | |
| 17.04.14 | AstraZeneca buy | UBS AG | |
| 16.04.14 | Volvo (B) Hold | Deutsche Bank AG | |
| 16.04.14 | Ericsson (Telefon L.M.Ericsson) (B) Outperform | Credit Suisse Group | |
| 15.04.14 | Ericsson (Telefon L.M.Ericsson) (B) buy | Deutsche Bank AG | |
| 15.04.14 | Nokia Hold | Deutsche Bank AG | |
| 15.04.14 | Ericsson (Telefon L.M.Ericsson) (B) overweight | JP Morgan Chase & Co. | |
| 15.04.14 | Nokia overweight | JP Morgan Chase & Co. | |
| 14.04.14 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 14.04.14 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 14.04.14 | Nokia Neutral | UBS AG | |
| 14.04.14 | Ericsson (Telefon L.M.Ericsson) (B) buy | UBS AG | |
| 10.04.14 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 09.04.14 | Nokia overweight | JP Morgan Chase & Co. | |
| 09.04.14 | Nokia Neutral | UBS AG | |
| 08.04.14 | Nokia Hold | Deutsche Bank AG | |
| 07.04.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.04.14 | AstraZeneca Hold | Deutsche Bank AG | |
| 01.04.14 | AstraZeneca buy | UBS AG | |
| 26.03.14 | Ericsson (Telefon L.M.Ericsson) (B) overweight | JP Morgan Chase & Co. | |
| 25.03.14 | Nokia overweight | JP Morgan Chase & Co. | |
| 24.03.14 | Volvo (B) Neutral | Goldman Sachs Group Inc. | |
| 21.03.14 | Nokia Equal-Weight | Morgan Stanley | |
| 20.03.14 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 19.03.14 | AstraZeneca Halten | Independent Research GmbH | |
| 17.03.14 | AstraZeneca Neutral | BNP PARIBAS | |
| 11.03.14 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 11.03.14 | Volvo (B) Underweight | Morgan Stanley | |
| 10.03.14 | Volvo (B) buy | Citigroup Corp. | |
| 10.03.14 | AstraZeneca neutral | Barclays Capital | |
| 07.03.14 | Nokia Outperform | Credit Suisse Group | |
| 06.03.14 | AstraZeneca buy | UBS AG | |
| 04.03.14 | Volvo (B) overweight | HSBC | |
| 04.03.14 | ABB (Asea Brown Boveri) Underweight | HSBC |
